FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

FDA Advisers Reject J&Js V-Wave Heart Shunt

An FDA advisory committee votes unanimously against recommending approval of Johnson & Johnsons V-Wave heart shunt for patients with advanced heart fa...

latest-news-card-1
Human Drugs

Device Compliance Official Flags Quality Gaps, Rising Enforcement

A senior CDRH compliance official warns industry that persistent shortcomings in complaint handling, corrective actions, and medical device reporting ...

latest-news-card-1
Human Drugs

Breyanzi OKd for Hard-to-Treat Marginal Zone Lymphoma

FDA approves Juno Therapeutics CAR-T therapy lisocabtagene maraleucel (Breyanzi) for adults with relapsed or refractory marginal zone lymphoma.

latest-news-card-1
Human Drugs

Bayesian Statistical Analysis Demonstration Project

FDA solicits proposals for the CDER Center for Clinical Trial Innovation Bayesian Statistical Analysis demonstration project.

latest-news-card-1
Biologics

CBER Inspections Challenged by Lack of Facility Readiness

CBER says that a common deficiency that is driving a significant share of BLA-related complete response letters is manufacturing facility inspection r...

latest-news-card-1
Human Drugs

Clinical Hold Lifted on Vandas Motion Sickness Studies

FDA lifts a partial clinical hold on one of Vanda Pharmaceuticals key tradipitant studies, clearing the company to expand dosing in an ongoing motion-...

latest-news-card-1
Medical Devices

Medical Device eCopy Submission Guidance

FDA publishes a guidance on implementing the eCopy submission program for medical devices.

latest-news-card-1
Medical Devices

FDA, CMS Launching Tempo Pilot

FDA launches a pilot with the Center for Medicare and Medicaid Innovation to promote access to certain digital health devices covered through a new Ce...

latest-news-card-1
Human Drugs

User Fees Could Incentivize U.S. Drug Development

FDA reportedly is exploring ways PDUFA fees can be adjusted to incentivize companies to hold clinical trials in the U.S. rather than overseas.

latest-news-card-1

Quarter 3 Drug and Device Recalled Units Higher: Sedgwick Index

The Sedgwick third-quarter recall index sees a sharp increase in the number of affected drug and medical device units.